Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies

MLA

Michelle Henley, et al. “Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies.” Chest, vol. 148, Oct. 2015, p. 724A. EBSCOhost, https://doi.org/10.1378/chest.2279661.

APA

Michelle Henley, Craig LaForce, Nicola Jessop, Andrew Pedinoff, Edward Kerwin, Robert Di Giovanni, & Peter D’Andrea. (2015). Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies. Chest, 148, 724A. https://doi.org/10.1378/chest.2279661

Chicago

Michelle Henley, Craig LaForce, Nicola Jessop, Andrew Pedinoff, Edward Kerwin, Robert Di Giovanni, and Peter D’Andrea. 2015. “Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies.” Chest 148 (October): 724A. doi:10.1378/chest.2279661.